EquiTrace uniquely understands the intersection of equine healthcare and technology and builds brilliant solutions that meet our users’ needs. Since launching in 2022, EquiTrace has gained a large user base, particularly in the US market.
EquiTrace solutions eliminate human error and build data integrity for those who work with horses. The EquiTrace App replaces pen and paper, giving detailed medical reports for each horse. EquiTrace uniquely connects to the new BioThermo microchip to give instant temperature readings to identify sick horses before the clinical signs are shown.
EquiTrace's medication platform uses a world-leading algorithm to compute actual withdrawal periods and detection times for over 1,000 medications. Complementing our core solutions is our breeding platform, which has intuitive reproduction recording features that trigger automatic schedules and to-do lists for all team members.
EquiTrace is now used by over 50% of the US Thoroughbred breeding industry, with clients such as Coolmore USA, Lanes End, Claiborne, Machmerhall, and Haygard Equine Medical Institute. EquiTrace recognizes multiple medication jurisdictions, including the FEI, AQHA, USEF, HISA, EHSLC, and more. EquiTrace integrates directly with the US Jockey Club and saves hours of time for its users who pair EquiTrace with Horse Farm Management.
EquiTrace continues to spend significantly in research & development to create new novel solutions to improve the health and welfare of horses.
